Cargando…
Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer
Gemcitabine has been reported to be a potent radiosensitiser in human pancreatic cell lines. This study was conducted to evaluate the efficacy and toxicity of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer. In all, 42 patients with pancreatic cancer that was unresectab...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364779/ https://www.ncbi.nlm.nih.gov/pubmed/15226765 http://dx.doi.org/10.1038/sj.bjc.6602001 |